Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Chubb
McKinsey
McKesson
Mallinckrodt
Dow
Baxter
Boehringer Ingelheim
Fish and Richardson
Novartis

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020841

« Back to Dashboard

NDA 020841 describes LOTEMAX, which is a drug marketed by Bausch And Lomb Inc, Bausch And Lomb, and Pharmos, and is included in four NDAs. It is available from two suppliers. Additional details are available on the LOTEMAX profile page.

The generic ingredient in LOTEMAX is loteprednol etabonate. There are nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the loteprednol etabonate profile page.
Summary for 020841
Tradename:LOTEMAX
Applicant:Pharmos
Ingredient:loteprednol etabonate
Patents:0
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020841

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION/DROPS;OPHTHALMICStrength0.5%
Approval Date:Mar 9, 1998TE:RLD:No

Expired US Patents for NDA 020841

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmos LOTEMAX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020841-001 Mar 9, 1998 ➤ Sign Up ➤ Sign Up
Pharmos LOTEMAX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020841-001 Mar 9, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
US Army
Baxter
Johnson and Johnson
Medtronic
Fish and Richardson
Federal Trade Commission
Julphar
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot